US Patent Issued to VANDERBILT UNIVERSITY on Jan. 27 for "Human monoclonal antibodies to hantavirus and methods of use therefore" (Tennessee Inventor)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,512, issued on Jan. 27, was assigned to VANDERBILT UNIVERSITY (Nashville, Tenn.).

"Human monoclonal antibodies to hantavirus and methods of use therefore" was invented by James E. Crowe Jr. (Nashville, Tenn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to antibodies binding to and neutralizing hantavirus and methods for use thereof."

The patent was filed on Nov. 10, 2020, under Application No. 17/775,942.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=...